View from Brussels

Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.

Articles

EMA continues to familiarize industry with new clinical trial legislation.

Dragging the Clinical Trials Community into Conformity

‘Independence’ the priority for the longstanding European Organization for Research and Treatment of Cancer, Winette van der Graaf tells Applied Clinical Trials in interview.

Exclusive: Meet the New Head of Europe’s Formidable Cancer Non-Profit

Stress the importance of clinical studies today—and urge for formal approach to managing the pandemic and addressing specific public health needs more sustainably.

Europe Policy Leaders Recognize COVID-Driven Trial Benefits

ICH draft guideline advocating a more comprehensive framework in optimizing pediatric drug development reaches next step.

Pediatric Extrapolation: The Next Stage in International Guidance on Trials

What to make of UK’s draft resolution set for review on the international stage.

UK Bidding to Influence Global Clinical Trials

Leaked draft gives glimpse into potential new research proposals as part of the EU’s Horizon program.


Promises of New Support—in Cash, Not Just Comments—for European Clinical Trials

Agency report reveals solid results from the first five years of its PRIME scheme, but also calls for improvements in focus.   

EMA: Product Prioritization Can Cut Approval Delays—but Could be Better Targeted 

Organization says either reform European drug development rules—or lose out on global competition.

 ACRO Offers Blunt Take on EU Clinical Trial Legislation Pursuits

EU’s new health innovation center unveils several projects focused on advancing R&D, medical countermeasures, and related technologies.

Moving from Rhetoric to Reality on Europe's HERA Health Crisis Center

2022 EU initiative provides hope for improvement of trial regulations.